Northacre PLC
05 December 2007
THE KENSINGTON
PLANNING CONSENT
Northacre plc is proud to announce that the Committee of the Royal Borough of
Kensington and Chelsea has unanimously voted in favour of granting a planning
consent for the residential and cinema development proposal on the Kensington
Odeon site.
The consent allows approximately 100,000 sq.ft. of private high-end residential
apartments and townhouses above ground with an all new six screen state of the
art Odeon cinema below ground.
The development site was acquired in a joint venture with Minerva plc in
November 2005.
John Hunter, Chief Executive of Northacre plc, said
' Following more than two years of public consultation we are proud to have
achieved planning consent for this residential and cinema scheme in prime
Central London. The Kensington will now be another landmark revival scheme.'
All Enquiries:
Northacre Plc 020 7349 8000
John Hunter, Chief Executive
Manish Santilale, Finance Director
KBC Peel Hunt Ltd 020 7418 8900
Capel Irwin
Nicholas Marren
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.